Gene · 7220
Papers2,976
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,976
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ca2+ Influx through TRPC Channels Is Regulated by Homocysteine-Copper Complexes. | Biomolecules | 2023 | 37371532 | PubTator, text mining | PubMed |
| Daphnetin, a Coumarin with Anticancer Potential against Human Melanoma: In Vitro Study of Its Effective Combination with Selected Cytostatic Drugs. | Cells | 2023 | 37371063 | PubTator, text mining | PubMed |
| Contribution of transient receptor potential canonical channels in human and experimental pulmonary arterial hypertension. | Am J Physiol Lung Cell Mol Physiol | 2023 | 37366608 | PubTator, text mining | PubMed |
| Editorial: The role of calcium and calcium binding proteins in cell physiology and disease. | Front Physiol | 2023 | 37362430 | PubTator, text mining | PubMed |
| TRP channels: Role in neurodegenerative diseases and therapeutic targets. | Heliyon | 2023 | 37332910 | PubTator, text mining | PubMed |
| Editorial: Transient receptor potential (TRP) ion channels in non-excitable cells. | Front Physiol | 2023 | 37260589 | PubTator, text mining | PubMed |
| ORAI Calcium Channels: Regulation, Function, Pharmacology, and Therapeutic Targets. | Pharmaceuticals (Basel) | 2023 | 37259313 | PubTator, text mining | PubMed |
| Diacerein modulates TLR4/ NF-κB/IL-1β and TRPC1/CHOP signalling pathways in gentamicin-induced parotid toxicity in rats. | J Cell Mol Med | 2023 | 37257043 | PubTator, text mining | PubMed |
| Pruritogenic molecules in the skin of patients with dermatomyositis. | Front Med (Lausanne) | 2023 | 37250649 | PubTator, text mining | PubMed |
| Role of Calcium Modulation in the Pathophysiology and Treatment of Alzheimer's Disease. | Int J Mol Sci | 2023 | 37240413 | PubTator, text mining | PubMed |
| Calcium's Role in Orchestrating Cancer Apoptosis: Mitochondrial-Centric Perspective. | Int J Mol Sci | 2023 | 37240331 | PubTator, text mining | PubMed |
| Calcium Homeostasis, Transporters, and Blockers in Health and Diseases of the Cardiovascular System. | Int J Mol Sci | 2023 | 37240147 | PubTator, text mining | PubMed |
| Pore residues of transient receptor potential channels canonical 1 and 4 heteromer determine channel properties. | Am J Physiol Cell Physiol | 2023 | 37212545 | PubTator, text mining | PubMed |
| Non-canonical helical transitions and conformational switching are associated with characteristic flexibility and disorder indices in TRP and Kv channels. | Channels (Austin) | 2023 | 37196183 | PubTator, text mining | PubMed |
| Electromagnetic fields regulate calcium-mediated cell fate of stem cells: osteogenesis, chondrogenesis and apoptosis. | Stem Cell Res Ther | 2023 | 37194107 | PubTator, text mining | PubMed |
| Immune and Hereditary Thrombotic Thrombocytopenic Purpura: Can ADAMTS13 Deficiency Alone Explain the Different Clinical Phenotypes? | J Clin Med | 2023 | 37176552 | PubTator, text mining | PubMed |
| Naturally-Occurring Tyrosinase Inhibitors Classified by Enzyme Kinetics and Copper Chelation. | Int J Mol Sci | 2023 | 37175965 | PubTator, text mining | PubMed |
| Targeting Nociceptive Neurons and Transient Receptor Potential Channels for the Treatment of Migraine. | Int J Mol Sci | 2023 | 37175602 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Neurogenic Lower Urinary Tract Dysfunction after Spinal Cord Injury. | Int J Mol Sci | 2023 | 37175592 | PubTator, text mining | PubMed |
| Targeting transient receptor potential canonical 1 reduces non‑small cell lung cancer chemoresistance and stemness via inhibition of PI3K/AKT signaling. | Oncol Lett | 2023 | 37153044 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7220/papers?page=11